{
    "2021-02-24": [
        [
            {
                "time": "",
                "original_text": "涨了100倍，掌握3大极好资产，华兰生物，现在依然值得强力关",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "涨",
                        "100倍",
                        "极好资产"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "华兰生物跌超6% 去年高点中信证券发研报喊买入",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "跌",
                        "6%",
                        "中信证券",
                        "研报",
                        "买入"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "新冠疫情影响下：流感疫苗“过冬天”",
                "features": {
                    "keywords": [
                        "新冠疫情",
                        "流感疫苗",
                        "过冬天"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-01",
                "original_text": "华兰生物：约515.29万股限售股3月1日解禁，占比0.2824% 解禁",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "限售股",
                        "解禁",
                        "3月1日"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "华兰生物(002007.SZ)：515.2875万股限制性股票将解锁上市流通",
                "features": {
                    "keywords": [
                        "华兰生物",
                        "限制性股票",
                        "解锁",
                        "上市流通"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}